## Abstract ## Background Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the
Treatment of small intestinal fistulas with octreotide, a somatostatin analog
โ Scribed by Guy M. Boike; Sterling E. Sightler; Hervy E. Averette
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 286 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Three patients with external small bowel fistulas were successfully treated with bowel rest, total parenteral nutrition, and the somatostatin analog, octreotide. Two of the patients had received prior multimodality therapy, including radiation, for gynecologic cancer. The time intervals to fistula closure were 2 days, 10 days, and 5 weeks after initiation of octreotide therapy. The efficacy of octreotide combined with total parenteral nutrition in the treatment of external enteric fistulas supports its routine use, especially in previously irradiated patients.
๐ SIMILAR VOLUMES
I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o
## BACKGROUND. Currently, there is no agreement regarding optimal treatment strate-